BostonGene to Highlight the Role of AI Foundation Models in Optimizing Cancer Immunotherapy at Precision Medicine World Conference 2026

Weekly Voice editorial staff
1 Min Read

WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced that Nathan Fowler, MD, Chief Medical Officer at BostonGene will deliver multiple presentations in the upcoming Precision Medicine World Conference (PMWC), held March 4-6 in Santa Clara, CA. The company will present data on how integrated multiomics and AI-driven analytics are being utilized to address complexities in cancer care and drug development. Throughou

- Advertisement -
Share This Article